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Abstract
Limbal stem cell de  ciency is implicated in many diseases and can be a reason for failure of different ocular 
surface reconstruction interventions, including penetrating keratoplasty. Classic clinical presentation includes the 
triad conjunctivalization, neovascularization, and chronic in  ammation demonstrated by clinical and instrumental 
methods like impression cytology, confocal microscopy, and other imaging techniques. Management of limbal 
epithelial stem cell de  ciency requires a complex approach and providing optimal conditions for limbal stem 
cell survival by correcting all coexistent pathophysiologic aberrations. A new direction in operative treatment is 
ex vivo expansion of autologous limbal epithelial stem cells obtained by minimally invasive limbal biopsy. With 
growing practical signi  cance of the disease new innovative methods for ocular surface reconstruction continue 
to arise, aiming at the best visual outcome.
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CLAU – Conjunctival Limbal Autograft, lr-CLAL – Living-related Conjunctival Limbal Allograft, 
KLAL – Keratolimbal Allograft, rhNGF – recombinant human nerve growth factor
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 1.        
.
SSCE – Sequential Sectoral Conjunctival Epitheliectomy, AM – Amniotic Membrane, CLAU – Con-
junctival Limbal Autograft, lr-CLAL – Living-related Conjunctival Limbal Allograft, KLAL – Kera-
tolimbal Allograft, COMET – Cultivated Oral Mucosal Epithelial Transplantation, IPSc – Induced 
Pluripotent Stem Cells 
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